Nvidia's deal with OpenAI has enormous implications for all stock market investors.
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFA23 Sept 2025, 21:43 UTC
AI-generated source summary
The analysis discusses Nvidia's potential investment of up to $100 billion in OpenAI and its implications for Nvidia stock investors. Nvidia stock is up over 3.5% on the back of this announcement. Oracle also reported it will have over $500 billion in orders to deploy a lot of its services and and a lot of that is going through OpenAI. The presenter estimates the Free Cash Flows for NVDA in billions of dollars with these values 2024: $46.7900, 2025: $64.5800, 2026: $101.3100, 2027: $132.00, 2028: $153.00, 2029: $186.00, and 2030: $207.00 the estimated current market price is $183.05 and a possible target for a very longer time frame is $207.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Signals in this source
More Prediction Case Files from Parkev Tatevosian, CFA
Coca-Cola Stock: Buy, Hold, or Sell? | KO Stock Analysis
SoFi Stock Analysis: Buy the Dip?
Should You Buy Micron Stock Instead of Nvidia Stock? | MU Stock vs. NVDA Stock
Should You Buy the Dip in Meta Stock? | META Stock Analysis and Live Earnings Review
Should Passive Income Investors Buy Colgate Palmolive Stock?
Procter & Gamble Stock: Buy, Hold, or Sell? | PG Stock Analysis
Parkev Tatevosian, CFA
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.